Proposed Data Collections Submitted for Public Comment and Recommendations, 53461-53463 [2013-21048]
Download as PDF
<![CDATA[
53461
Federal Register / Vol. 78, No. 168 / Thursday, August 29, 2013 / Notices
By direction of the Commission,
Commissioner Wright not participating.
Donald S. Clark,
Secretary.
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
[FR Doc. 2013–21158 Filed 8–28–13; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–13–13JQ]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Health Professional Application for
Training (HPAT)—New —National
Center for HIV/AIDS, Viral Hepatitis,
CDC/NCHHSTP is requesting OMB
approval to collect data that will be
used to monitor and evaluate
performance of CDC funded grantees
that offer Sexually Transmitted Disease
(STD) and Human immunodeficiency
virus (HIV) prevention training, training
assistance, and capacity building
assistance to physicians, nurses, disease
intervention specialists, health
educators and other public health
professionals. Information collection
approval is sought for three years.
CDC/NCHHSTP will use the Health
Professional Application for Training
(HPAT) for this data collection. This
instrument was previously approved
under OMB clearance #0920–0017 as a
Participant Information Form, but was
removed from that information
collection request upon its most recent
revision. The HPAT allows CDC
grantees to use a single instrument
when partnering with other Health and
Human Services (HHS) funded training
programs and does not duplicate
information collection efforts. The
HPAT will serve as the official training
application form used for training
activities conducted by the CDC-funded
STD/HIV Prevention Training Centers’
(PTCs) and the HIV Capacity Building
Assistance (CBAs) grantees who offer
classroom and experiential training,
web-based training, clinical
consultation, and capacity building
assistance to maintain and enhance the
capacity of health care professionals to
control and prevent STDs and HIV.
The HPAT will also be used to collect
information from the training
participants regarding their: (1)
Occupations, professions, and
functional roles; (2) principal
employment settings; (3) location of
their work settings; and (4)
programmatic and population foci of
their work. This data collection
provides CDC with information to
determine whether the training grantees
are reaching their target audiences in
terms of provider type, the types of
organizations in which participants
work, the focus of their work and the
population groups and geographic areas
served; the data collection is also used
to triage and assign CBA provider
requests.
The 7,400 respondents represent an
average of the number of health
professionals trained by the CBA and
PTC grantees during the years 2010 and
2011. There are no costs to respondents
other than their time.
It is estimated that this collection will
involve a total of 617 annual burden
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Healthcare Professionals ........
Health Professional Application for Training (HPAT) .............
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–21087 Filed 8–28–13; 8:45 am]
Centers for Disease Control and
Prevention
[60Day–13–0910]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
BILLING CODE 4163–18–P
sroberts on DSK5SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
VerDate Mar<15>2010
18:34 Aug 28, 2013
Jkt 229001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
7,400
Number
responses per
respondent
1
Average
burden per
response
(in hours)
5/60
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS D–74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
E:\FR\FM\29AUN1.SGM
29AUN1
53462
Federal Register / Vol. 78, No. 168 / Thursday, August 29, 2013 / Notices
be received within 60 days of this
notice.
Proposed Project
Message Testing for Tobacco
Communication Activities (OMB No.
0920–0910, exp. 1/31/2015)—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Tobacco use remains the leading
preventable cause of death in the United
States. Recent legislative developments
highlight the importance of tobacco
control—including the dissemination of
appropriate tobacco control messages—
in efforts to improve the nation’s health.
These developments include the
Prevention and Public Health Fund,
established by the Affordable Care Act
(ACA), which supports initiatives
designed to reduce the health and
financial burden of tobacco use through
prevention and cessation approaches.
An essential component of this
initiative is a national campaign to
increase awareness of the health
consequences of tobacco use and
exposure to secondhand smoke. The
campaign is being planned and
implemented by the Office on Smoking
and Health (OSH) at the Centers for
Disease Control and Prevention (CDC).
OSH serves as a resource for tobacco
and health information for the public,
health professionals, various branches
of government, and other interested
groups.
In 2012, OSH obtained OMB approval
of a generic clearance that established a
unified information collection
framework for the development of
tobacco-related health messages,
including messages related to the ACAfunded tobacco education campaign
and testing of tobacco-related health
messages for the general public and
subpopulations. For example, screening
activities may be conducted to involve
individuals who are Lesbian, Gay,
Bisexual, and Transgender (LGBT);
individuals who are active military or
veterans; individuals who suffer from
depression and/or anxiety, and
individuals who are English-speaking
Hispanics. CDC may also request
information about smoking status (e.g.,
current non-smoker, current smoker, exsmoker). Screening results will be used
to segment target audiences, interpret
findings, and explore the development
of tailored messages for population
subgroups. The estimated burden per
response for screening is 2–3 minutes.
CDC will continue to use the MTTCA
clearance to develop and test messages
and materials for current and future
phases of the ACA-funded media
campaign, OSH’s ongoing programmatic
initiatives including the Media
Campaign Resource Center (MCRC) and
reports from the Office of the Surgeon
General, and collaborative efforts within
CDC. The MTTCA generic clearance
may also be used to facilitate the
development of tobacco-related health
communications of interest to CDC and
other federal partners, including the
Food and Drug Administration (FDA),
the Substance Abuse and Mental Health
Services Administration (SAMHSA), the
National Institutes of Health (NIH), and
the National Cancer Institute (NCI).
The revision request does not affect
the current expiration date of January
31, 2015. The estimated annualized
number of responses will increase from
14,974 to 34,974 and the estimated
annualized burden hours will increase
from 5,775 to 6,442. Participation is
voluntary and there are no costs to
respondents other than their time.
(Message Testing for Tobacco
Communication Activities (MTTCA),
OMB No. 0920–0910, exp. 1/31/2015).
Since that time, CDC has employed the
MTTCA clearance to collect information
about smokers’ and non-smokers’
attitudes and perceptions, and to pretest draft messages and materials for
clarity, salience, appeal, and
persuasiveness. A variety of information
collection strategies are supported
through this mechanism, including indepth interviews, in-person focus
groups, online focus groups, computerassisted, in-person, or telephone
interviews, and online surveys. CDC
requests OMB approval for each data
collection by submitting an Information
Collection Request that describes project
purpose, use, and methodology. CDC’s
authority to collect information for
public health purposes is provided by
the Public Health Service Act (41 U.S.C.
241) Section 301.
CDC plans to revise the generic
MTTCA clearance, which was initially
approved with the following estimates:
5,775 annualized burden hours and
14,974 annualized responses. The initial
estimates were based on the number of
respondents who were likely to
participate in information collection
activities such as focus groups,
interviews, and surveys. The initial
estimates did not account for specific
screening activities that are necessary to
identify respondents from key target
audiences. As a result, the initial
MTTCA clearance underestimated the
total number of respondents involved in
CDC-sponsored information collection.
The planned revision will adjust for
screening and recruitment by allocating
20,000 additional respondents, and 667
additional burden hours, to the
annualized estimates.
The generic MTTCA clearance will
continue to support the development
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Data collection
method
Number of
responses per
respondent
Average
burden per
response
Total burden
(in hours)
Total ...........................................
VerDate Mar<15>2010
18:34 Aug 28, 2013
Screening and Recruitment .............
In-depth Interviews (In Person, telephone, etc.).
Focus Groups (In Person) ...............
Focus Groups (Online) ....................
20,000
67
1
1
2/60
1
667
67
160
120
1
1
1.5
1
240
120
Short Surveys (Online, Bulletin
Board, etc.).
Medium Surveys (Online) ................
In-depth Surveys (Online) ................
General Public and Special Populations.
sroberts on DSK5SPTVN1PROD with NOTICES
Number of
respondents
6,001
1
10/60
1,000
7,334
1,292
1
1
25/60
1
3,056
1,292
..........................................................
34,974
........................
........................
6,442
Jkt 229001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\29AUN1.SGM
29AUN1
Federal Register / Vol. 78, No. 168 / Thursday, August 29, 2013 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2013–21048 Filed 8–28–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
sroberts on DSK5SPTVN1PROD with NOTICES
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Population Sciences and
Epidemiology.
Date: September 19, 2013.
Time: 12:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Fungai Chanetsa, MPH,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–408–
9436, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurotransporters, Receptors,
and Calcium Signaling Study Section.
Date: September 26, 2013.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel & Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Peter B Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4182,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Drug Discovery and Molecular
Pharmacology Study Section.
VerDate Mar<15>2010
18:34 Aug 28, 2013
Jkt 229001
Date: September 30, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Seattle Hotel, 515
Madison Street, Seattle, WA 98104.
Contact Person: Jeffrey Smiley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194,
MSC 7804, Bethesda, MD 20892, 301–594–
7945, smileyja@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Health Services Organization and Delivery
Study Section.
Date: September 30–October 1, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 806–
0009, brontetinkewjm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 23, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–21026 Filed 8–28–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Clinical Trials
and Translational Research Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Agenda: Strategic Discussion of NCI’s
Clinical and Translational Research
Programs.
Place: National Institutes of Health,
Building 31, C-Wing, 6th Floor, 31 Center
Drive, Conference Rooms 10, Bethesda, MD
20892.
Contact Person: Sheila A. Prindiville, MD,
MPH, Director, Coordinating Center for
Clinical Trials, National Cancer Institute,
National Institutes of Health, 9609 Medical
Center Drive Room 6W136, Rockville, MD
20850, 240–276–6173, prindivs@
mail.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ctac/
ctac.htm, where an agenda and any
additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 23, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–21027 Filed 8–28–13; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee.
Date: November 06, 2013.
Time: 9:00 a.m. to 4:00 p.m.
PO 00000
Frm 00042
Fmt 4703
Sfmt 9990
53463
E:\FR\FM\29AUN1.SGM
29AUN1
]]>Agencies
[Federal Register Volume 78, Number 168 (Thursday, August 29, 2013)]
[Notices]
[Pages 53461-53463]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-21048]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-13-0910]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Leroy Richardson, 1600 Clifton Road, MS D-74, Atlanta,
GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should
[[Page 53462]]
be received within 60 days of this notice.
Proposed Project
Message Testing for Tobacco Communication Activities (OMB No. 0920-
0910, exp. 1/31/2015)--Revision--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Tobacco use remains the leading preventable cause of death in the
United States. Recent legislative developments highlight the importance
of tobacco control--including the dissemination of appropriate tobacco
control messages--in efforts to improve the nation's health. These
developments include the Prevention and Public Health Fund, established
by the Affordable Care Act (ACA), which supports initiatives designed
to reduce the health and financial burden of tobacco use through
prevention and cessation approaches. An essential component of this
initiative is a national campaign to increase awareness of the health
consequences of tobacco use and exposure to secondhand smoke. The
campaign is being planned and implemented by the Office on Smoking and
Health (OSH) at the Centers for Disease Control and Prevention (CDC).
OSH serves as a resource for tobacco and health information for the
public, health professionals, various branches of government, and other
interested groups.
In 2012, OSH obtained OMB approval of a generic clearance that
established a unified information collection framework for the
development of tobacco-related health messages, including messages
related to the ACA-funded tobacco education campaign (Message Testing
for Tobacco Communication Activities (MTTCA), OMB No. 0920-0910, exp.
1/31/2015). Since that time, CDC has employed the MTTCA clearance to
collect information about smokers' and non-smokers' attitudes and
perceptions, and to pre-test draft messages and materials for clarity,
salience, appeal, and persuasiveness. A variety of information
collection strategies are supported through this mechanism, including
in-depth interviews, in-person focus groups, online focus groups,
computer-assisted, in-person, or telephone interviews, and online
surveys. CDC requests OMB approval for each data collection by
submitting an Information Collection Request that describes project
purpose, use, and methodology. CDC's authority to collect information
for public health purposes is provided by the Public Health Service Act
(41 U.S.C. 241) Section 301.
CDC plans to revise the generic MTTCA clearance, which was
initially approved with the following estimates: 5,775 annualized
burden hours and 14,974 annualized responses. The initial estimates
were based on the number of respondents who were likely to participate
in information collection activities such as focus groups, interviews,
and surveys. The initial estimates did not account for specific
screening activities that are necessary to identify respondents from
key target audiences. As a result, the initial MTTCA clearance
underestimated the total number of respondents involved in CDC-
sponsored information collection. The planned revision will adjust for
screening and recruitment by allocating 20,000 additional respondents,
and 667 additional burden hours, to the annualized estimates.
The generic MTTCA clearance will continue to support the
development and testing of tobacco-related health messages for the
general public and subpopulations. For example, screening activities
may be conducted to involve individuals who are Lesbian, Gay, Bisexual,
and Transgender (LGBT); individuals who are active military or
veterans; individuals who suffer from depression and/or anxiety, and
individuals who are English-speaking Hispanics. CDC may also request
information about smoking status (e.g., current non-smoker, current
smoker, ex-smoker). Screening results will be used to segment target
audiences, interpret findings, and explore the development of tailored
messages for population subgroups. The estimated burden per response
for screening is 2-3 minutes.
CDC will continue to use the MTTCA clearance to develop and test
messages and materials for current and future phases of the ACA-funded
media campaign, OSH's ongoing programmatic initiatives including the
Media Campaign Resource Center (MCRC) and reports from the Office of
the Surgeon General, and collaborative efforts within CDC. The MTTCA
generic clearance may also be used to facilitate the development of
tobacco-related health communications of interest to CDC and other
federal partners, including the Food and Drug Administration (FDA), the
Substance Abuse and Mental Health Services Administration (SAMHSA), the
National Institutes of Health (NIH), and the National Cancer Institute
(NCI).
The revision request does not affect the current expiration date of
January 31, 2015. The estimated annualized number of responses will
increase from 14,974 to 34,974 and the estimated annualized burden
hours will increase from 5,775 to 6,442. Participation is voluntary and
there are no costs to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average
Type of respondents Data collection method Number of responses per burden per Total burden
respondents respondent response (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Screening and Recruitment................ 20,000 1 2/60 667
In-depth Interviews (In Person, 67 1 1 67
telephone, etc.).
Focus Groups (In Person)................. 160 1 1.5 240
General Public and Special Populations....... Focus Groups (Online).................... 120 1 1 120
Short Surveys (Online, Bulletin Board, 6,001 1 10/60 1,000
etc.).
Medium Surveys (Online).................. 7,334 1 25/60 3,056
In-depth Surveys (Online)................ 1,292 1 1 1,292
---------------------------------------------------------------
Total.................................... ......................................... 34,974 .............. .............. 6,442
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 53463]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention (CDC).
[FR Doc. 2013-21048 Filed 8-28-13; 8:45 am]
BILLING CODE 4163-18-P
